Emblem Announces $25 Million Bought Deal

Emblem Corp. (TSX VENTURE:EMC)(TSX VENTURE:EMC.WT) announces that it has entered into a letter of engagement with Eight Capital under which Eight Capital has agreed to purchase 5,714,300 units (the "Units") and 15,000 convertible unsecured debentures of the Company

ABcann Global Puts The 'Green' In Green Rush

Seekingalpha.com recently posted an in-depth article looking at ABcann Global (TSX.V: ABCN OTCQB: ABCCF) and how well positioned it is in this emerging market. It's a great read for those interested in this company that we've identified as one of Canada's Strongest Growers.

InMed Pharmaceuticals pursues medical qualities of cannabis — no smoke

People with such serious medical conditions as glaucoma and multiple sclerosis may smoke marijuana to deliver a range of chemicals that they believe helps improve their conditions. The problem is that a joint might just be one of the least effective methods to deliver some of the 90+ cannabinoids found in cannabis.